Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Free Respiratory Health Screenings Offered to Coal Miners

Free Respiratory Health Screenings Offered to Coal Miners News & Analysis Health Agencies Update FDA Approves First Sublingual of death, spinal cord infarction, paraplegia, Therapies for Allergic Rhinitis quadriplegia, cortical blindness, stroke, sei- The US Food and Drug Administration (FDA) zures, nerve injury, and brain swelling in pa- approved the first sublingual allergen ex- tients who had received epidural steroid in- tract for treatment of allergic rhinitis, in this jections. These events occurred within case for symptoms induced by exposure to minutes to 2 days after injection. According grass pollen, on April 2 (http://1.usa.gov to the FDA, many of the patients did not re- /1mKpSNe). cover from these injuries. A growing body of evidence has sug- Based on these findings, the FDA is re- gested that desensitizing patients with al- quiring a warning on the label of these drugs lergies by sublingual exposure to tiny alerting physicians and patients to these po- amounts of allergen may be effective. The tential risks. The FDA also plans to convene new product, Oralair, consists of freeze- an advisory committee to assess the risks dried extracts of pollen from 5 common later this year, and the FDA Safe Use Initia- grasses (Kentucky bluegrass, orchard, pe- tive is expected to release recommenda- http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Free Respiratory Health Screenings Offered to Coal Miners

Kuehn, Bridget M.
JAMA , Volume 311 (20) – May 28, 2014
Download PDF
1 page

Free Respiratory Health Screenings Offered to Coal Miners

Abstract

News & Analysis Health Agencies Update FDA Approves First Sublingual of death, spinal cord infarction, paraplegia, Therapies for Allergic Rhinitis quadriplegia, cortical blindness, stroke, sei- The US Food and Drug Administration (FDA) zures, nerve injury, and brain swelling in pa- approved the first sublingual allergen ex- tients who had received epidural steroid in- tract for treatment of allergic rhinitis, in this jections. These events occurred within case for symptoms induced by...
Loading next page...
 
/lp/american-medical-association/free-respiratory-health-screenings-offered-to-coal-miners-yjOKQF0b1N

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2014.5420
Publisher site
See Article on Publisher Site

Abstract

News & Analysis Health Agencies Update FDA Approves First Sublingual of death, spinal cord infarction, paraplegia, Therapies for Allergic Rhinitis quadriplegia, cortical blindness, stroke, sei- The US Food and Drug Administration (FDA) zures, nerve injury, and brain swelling in pa- approved the first sublingual allergen ex- tients who had received epidural steroid in- tract for treatment of allergic rhinitis, in this jections. These events occurred within case for symptoms induced by exposure to minutes to 2 days after injection. According grass pollen, on April 2 (http://1.usa.gov to the FDA, many of the patients did not re- /1mKpSNe). cover from these injuries. A growing body of evidence has sug- Based on these findings, the FDA is re- gested that desensitizing patients with al- quiring a warning on the label of these drugs lergies by sublingual exposure to tiny alerting physicians and patients to these po- amounts of allergen may be effective. The tential risks. The FDA also plans to convene new product, Oralair, consists of freeze- an advisory committee to assess the risks dried extracts of pollen from 5 common later this year, and the FDA Safe Use Initia- grasses (Kentucky bluegrass, orchard, pe- tive is expected to release recommenda-

Journal

JAMA – American Medical Association

Published: May 28, 2014

There are no references for this article.